FDA Inspection 1017659 — Chongqing Land Tower Pharmaceutical Co., Ltd.
The FDA completed an inspection of Chongqing Land Tower Pharmaceutical Co., Ltd. on April 14, 2017 in Changshou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changshou (China)